Ingredion Stock Price Continuation Pattern On Seasonal Play

Ingredion stock price could move over the next 12 weeks if its seasonal pattern holds. Over the next 12 weeks, Ingredion stock price has on average risen by 12% based on the past 19 years of stock performance. Ingredion has risen higher in 17 of those 19 years over the next 12 week period, corresponding to a probability of 89%.
Continue reading “Ingredion Stock Price Continuation Pattern On Seasonal Play”

USANA Health Sciences TMF Higher On Launch of New Products in Canada

USANA Health Sciences’ Twiggs Money Flow is rocketing higher on the launch of two new products in Canada.
Continue reading “USANA Health Sciences TMF Higher On Launch of New Products in Canada”

Glu Mobile Stock Turnaround Play On Rising Large Players Volume

Glu Mobile stock is a turnaround candidate after the company signed a major deal with pop singer Taylor Swift. Glu Mobile will launch “The Swift Life”, a social platform from Taylor Swift that will let fans have direct engagement with her. Taylor Swift has millions of followers across various social networks.
Continue reading “Glu Mobile Stock Turnaround Play On Rising Large Players Volume”

General Finance Corporation Insider Buying On Disaster Relief

General Finance Corporation stock has a rising Twiggs Money Flow on a surge in insider buying in the wake of rebuilding efforts after the hurricane disasters. I have bought General Finance in my personal trading account this morning.

General Finance Corporation is a rental services company that provides portable storage, modular space, and liquid containment solutions in North America and the Asia-Pacific regions. Its portable storage products include storage containers used in classroom equipment storage, construction equipment and tool storage, disaster shelters, landscaping sheds, recreational equipment storage, and retail inventory storage applications; and freight containers used in freight transportation by road and rail.
Continue reading “General Finance Corporation Insider Buying On Disaster Relief”

Vipshop Holdings Rising Large Players Volume

I bought some Vipshop Holdings stock in my personal trading account this morning. The relative strength is awesome. The Effective Volume study shows large players volume is in a strong uptrend.
Continue reading “Vipshop Holdings Rising Large Players Volume”

Amazon Stock Twiggs Money Flow Breaks Positive

The Twiggs Money Flow on Amazon stock has broken above the zero line and has gone positive for the first time since August 7, 2017.

Amazon just rolled out Amazon Fresh in my area of Fresno, California. I signed up for the 14-day trial for Amazon Fresh and immediately canceled it because of the poor delivery times. On Saturday, I ordered 4 peaches, and a bag of shredded mild cheddar cheese. Amazon Fresh said they could not deliver it until Tuesday, LOL. I cancelled and told them I’ll just go to the grocery store myself and pick up these items in like a hour. If Amazon Fresh is going to be successful, they have to get delivery times down to same-day and at most, one day later. If they can’t do that they might as well close down their Amazon Fresh website because only the elderly and disabled are going to be willing to wait 3 or more days for their groceries to be delivered.

I think Amazon is poorly executing on their Amazon Fresh division. Amazon Fresh wasted about an hour of my time when you include the time it took me to order and then to cancel my order as well as my Amazon Fresh trial. I won’t try Amazon Fresh again for a long time. Maybe I’ll never try it again. That’s the cold hard reality of retail: first impressions are everything. Amazon has blown it in their roll out of Amazon Fresh by promising too much and then not delivering. Still, if any company can turn this around it’s Amazon.

MKM Partners recently gave Amazon a target price of $3,330 which you can read about here.

I’ve been trading in and out of Amazon stock for about a month now and it’s been a great stock to swing trade.

Amazon Stock

Amazon stock looks strong.

That’s a good basing pattern and perhaps even an inverted Head and Shoulders pattern. The 50 day moving average (blue line) is setting up a possible breakout play. Here is a swing trading lesson on breakout chart patterns.

In addition to the Twiggs Money Flow going positive, the Effective Volume study shows large players volume is still in an uptrend.

Prices have been consolidating lately forming a momentum squeeze on the chart:

The TSI is holding its buy signal cross from August 30, 2017.

There is very little resistance above the current price. There is a support zone below the current price at $972.24, a stop order could be placed below this zone.

Oconee Federal Financial Stock Heavy Institutional Buying

The stock of Oconee Federal Financial stock is seeing heavy institutional trader accumulation. The three-month change in institutional ownership is a whopping +21.6%.

Oconee Federal continues to earn Bauer Financial’s 5-Star Superior Rating. This rating means Oconee Federal is among the strongest financial institutions in the country. You can find out more about Oconee Federal Financial here.

The problem I have with this stock is that I can’t identify the catalyst that is driving it higher. I talk about the importance of identifying catalysts in this lesson.

Oconee Federal Financial Stock

Oconee Federal Financial stock

The stock is thinly traded with an average volume of about 2.8K so you have to be careful trading this stock. The Effective Volume study shows that large players are accumulating the stock which supports the increase in institutional ownership. The Twiggs Money Flow is positive which also supports the idea that this stock is being accumulated.

I see this stock as a short term swing trade with the goal of a 5% profit then get out quickly. I like the clearly defined stop loss level of $26.50 in case the trade goes against us.

Clovis Oncology Stock Rising Off Uptrend Channel Line

Clovis Oncology stock is rising off its uptrend channel line as large players volume continues to rise. The uptrend is also supported by the Twiggs Money Flow which is slowly rising. I dipped my toe in the water and purchased a little bit of Clovis Oncology stock today.

Clovis Oncology News

Since the company reported earnings on August 2, 2017, Clovis Oncology shares have lost about -8%. Clovis reported a second-quarter 2017 loss of -$1.29 per share, which was narrower than the year-ago loss of -$2.07 per share. The reported loss was greater than analysts forecast of -$1.27.

Net product revenues, entirely from Rubraca, were approximately $14.6 million in the quarter, up 108.6% sequentially. Revenues beat the consensus estimate of $12.54 million. The company said that 750 new patients were registered in the quarter.

Clovis Oncology’s Rubraca has shown an impressive growth trend in 2017. The drug received accelerated approval in Dec 2016. Rubraca is a PARP inhibitor, which is approved as a monotherapy for the treatment of advanced ovarian cancer in patients who have been treated with two or more chemotherapies. Rubraca has had an almost 100% growth in sales sequentially in the second quarter of 2017. Rubraca sales were $21.7 million in the first half of 2017. The company had 1100 new patients on therapy in the period.

Two confirmatory studies – ARIEL-3 and ARIEL-4 – are being conducted by Clovis for converting the accelerated approval to continued approval of Rubraca. The company’s shares got a boost when it announced positive top-line results from ARIEL 3 in June 2017. Progression-free survival (PFS) and safety results from the ARIEL-3 study demonstrated that Rubraca had a meaningful impact in delaying disease recurrence in advanced ovarian cancer patients. Clovis is planning to file a supplemental new drug application (sNDA) to the FDA by October this year based on ARIEL-3 data to include second-line or later maintenance indication for advanced ovarian cancer on the label of Rubraca. The company expects the label expansion to increase patient population by at least four times.

Rubraca is under review in the EU for a comparable ovarian cancer indication. An approval is expected from the EU in the first quarter of 2018.

I’m hearing rumors circulating that Clovis Oncology could be a takeover candidate by the end of the year because of Rubraca and the fact that Gilead bought KITE at the end of August.

You can find out more about Clovis Oncology here.

Clovis Oncology Stock Price

Clovis Oncology stock

Clovis Oncology stock usually swings higher at this time of year according to a seasonality study. Clovis Oncology stock is rising nicely off its uptrend line. The Effective Volume study shows large players volume rising. The Twiggs Money Flow is also rising which supports the thesis that large players are accumulating Clovis Oncology stock. I explain a lot of these chart patterns on the Frequently Asked Questions page here.

CLVS does present a good setup opportunity. Prices have been consolidating lately. There is a support zone below the current price at $72.66, a stop order could be placed below this zone.

CVD Equipment Corporation Pocket Pivot, Rising Large Players Volume

CVD Equipment Corporation has given a Pocket Pivot buy signal on rising large players volume according to the Effective Volume study.

On August 14, 2017, CVD Equipment Corporation reported revenue for Q2 2017 of $10.8 million, an increase of 12.2% over the prior quarter and 189.3% from the same period last year. During the quarter, the Company received approximately $6 million in new orders. Backlog as of June 30, 2017, was $24.8 million. Net income for the second quarter was $1.3 million compared to $1 million in the prior quarter and a loss of ($496,000) a year ago. Net earnings per diluted share increased to $0.20 from $0.16 in the first quarter and a net loss of ($0.08) in the second quarter of 2016.

Leonard Rosenbaum, President and Chief Executive Officer said, “Solid execution of our growth strategy led to record revenue and strong profitability in the quarter. As we deliver and execute on our large aviation project and rebuild our core business pipeline, we are achieving exceptional results. The strong performance of our systems in the field and our ongoing development of additional coating products will generate future demand in a variety of new and adjacent markets.” You can find out more about this company here.

CVD Equipment Corporation Chart

CVD Equipment Corporation stock chart.

CVV has formed a good setup pattern. Prices have been consolidating lately and the volatility has been reduced. There is a resistance zone just above the current price starting at $11.58. Right above this resistance zone may be a good entry point. There is a support zone below the current price at $11.13, a stop order could be placed below this zone. We notice that large players showed an interest for CVV in the last couple of days, which is a good sign. A Pocket Pivot signal also happened today which is another positive sign.

CVV has many of the technical signals that I wrote about in this lesson on how to find stocks here.

The stock screener I used to find CVV is the one I created for GuerillaStockTrading readers on Chartmill, under the Shared Screens tab, called GST Positive Divergence. I did a video on the GST Positive Divergence stock screener here. I also did a stock trading lesson on Pocket Pivots and large players volume here.